Similarly, in a meta-analysis of breast cancer, a high NLR was found to be associated with an adverse disease-free survival and overall survival, with a greater association with disease-specific outcome in estrogen receptor and HER-2 negative disease. Here, ERBB2 is linked to breast cancer.